MedTrace Logo

Immediate Versus Interval Postpartum Use of the Levonorgestrel Contraceptive Implants: a Randomized Controlled Trial

NCT02341027 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 205

Last updated 2020-02-17

No results posted yet for this study

Summary

This study will evaluate if immediate postpartum placement of a levonorgestrel (LNG) contraceptive implant within 5 days of delivery improves implant utilization at 6 months postpartum compared to implant placement at 6-8 weeks postpartum among women in Uganda.

Conditions

  • Contraceptive Implant Utilization
  • Lactation

Interventions

DEVICE

Jadelle

within 5 days of delivery and before discharge from hospital

DEVICE

Jadelle

6-8 weeks (42-56 days) postpartum

Sponsors & Collaborators

Principal Investigators

  • Sarah Averbach, MD · University of California, San Francisco

  • Jody Steinauer, MD, MAS · University of California, San Francisco

  • Josephat Byamugisha, MBChB, PhD · Mulago Hospital and Makerere University College of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02341027 on ClinicalTrials.gov